<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0001903'>Anemia</z:hpo> is the most common hematologic condition encountered in outpatient clinics </plain></SENT>
<SENT sid="1" pm="."><plain>It is often overlooked because it is common among patients; however, <z:hpo ids='HP_0001903'>anemia</z:hpo> is one of the leading indicators of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>This study examined the prevalence and characteristics of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> among <z:hpo ids='HP_0001903'>anemia</z:hpo> patients who visited an outpatient clinic </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: The data were collected by reviewing the records of an outpatient clinic from January 2007 to December 2011 </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In total, 502 patients (52 males, 450 females) were diagnosed with <z:hpo ids='HP_0001903'>anemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> prevalence among <z:hpo ids='HP_0001903'>anemia</z:hpo> patients was 5.57% (25.0%, men; 3.3%, women); further, the most frequently diagnosed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (22.5%), followed by advanced <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> (16.1%), <z:hpo ids='HP_0003002'>breast cancer</z:hpo> (9.6%), <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (9.6%), <z:e sem="disease" ids="C0302592" disease_type="Neoplastic Process" abbrv="">cervical cancer</z:e> (6.4%), <z:hpo ids='HP_0005584'>renal-cell carcinoma</z:hpo> (6.4%), and <z:e sem="disease" ids="C0007115" disease_type="Neoplastic Process" abbrv="">thyroid cancer</z:e> (6.4%) </plain></SENT>
<SENT sid="6" pm="."><plain>The prevalence of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was 4.1% in those aged 40-49 years, 4.2% in the subjects in their fifties, 8.0% in those in their sixties, 21.6% in those in their seventies, and 55.6% in those aged over 80 years </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevalence among <z:hpo ids='HP_0001891'>iron deficiency anemia</z:hpo> (IDA) patients was 6.18% (28.8%, men; 3.5%, women) </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevalence in postmenopausal and premenopausal female IDA patients was 16.0% and 1.6%, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Among <z:hpo ids='HP_0001903'>anemia</z:hpo> patients, male patients aged over 40 years and female patients aged over 60 years, along with postmenopausal female patients, were more likely to be diagnosed with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Consequently, male IDA patients, and female patients aged over 60 years must be carefully evaluated for the possibility of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
</text></document>